Skip to main content
NIH funding notice PAR-14-206

HIV Vaccine Research and Design (HIVRAD) Program (P01)

Closed on July 29, 2014.

Posted
May 5, 2014
Close date
July 29, 2014
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $7,388,989 in first-year total cost, median $2,440,281.

Most frequent study sections

  1. Special Emphasis Panel[ZAI1 KP-A (J1)]3

Most frequent institutions

  1. DUKE UNIVERSITY2
  2. WEILL MEDICAL COLL OF CORNELL UNIV1
Competing awards under PAR-14-206 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2015Cleaved, stabilized HIV-1 Env trimers for structural and vaccine studies1P01AI110657-01A1MOORE, JOHN PWEILL MEDICAL COLL OF CORNELL UNIV, NY$3,100,000ZAI1
2015Maternal and infant immunization to eliminate breast milk transmission of HIV-11P01AI117915-01PERMAR, SALLIE R.DUKE UNIVERSITY, NC$2,440,281ZAI1
2015Integrase Defective Lentiviral Vector (IDLV)-ENV Immunogen Strategy for an HIV Vaccine1P01AI110485-01A1KLOTMAN, MARY E.DUKE UNIVERSITY, NC$1,848,708ZAI1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.